EUVIMEDEUVIMED entdecken
Open Access

Enhancing Continence Recovery After Robot‐Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation

Yasunari Tanaka, Fumitaka Shimizu, Abulaiti Abudurezake, Myriam Diabangouaya, Yoshihiro Ikehata iD, Takuro Kobayashi iD, Toshiyuki China, Yoshifumi Tamura, Hisamitsu Ide, Shigeo Horie

The Prostate · 2026

DOI: 10.1002/pros.70205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2026. Verfasst von Yasunari Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Testosterone, Prostatectomy, Urinary Incontinence, Robotic Surgical Procedures. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urinary incontinence (UI) may persist in some patients after robot‐assisted radical prostatectomy (RARP), significantly affecting quality of life (QOL). This study investigated the changes in UI and pelvic floor muscle (PFM) volume in patients with persistent UI after RARP who underwent testosterone replacement therapy (TRT).

Methods

Patients with persistent UI after RARP who exhibited symptoms of late‐onset hypogonadism (LOH) and had no evidence of prostate cancer recurrence received TRT for 6 months. Magnetic stimulation (MS) was additionally performed upon patients' request. Blood tests, 1‐h pad test, urinary symptom questionnaires, and muscle mass evaluation were performed before and after TRT. PFM volume was measured by thin‐slice computed tomography.

Results

Thirty patients were enrolled, 15 of whom received MS in addition to TRT. Pad weight significantly decreased after TRT (mean change ± standard deviation [SD]: −44.1 ± 67.6 g; p = 0.001; 95% confidence interval: −69.3 g, −18.8 g), with no significant difference between the MS and non‐MS groups. However, only the MS group showed significant improvements in questionnaire scores (Overactive Bladder Symptom Score: p = 0.045; International Prostate Symptom Score [IPSS]: p = 0.041; IPSS‐QOL: p = 0.022) and an increase in PFM volume (mean ± SD: 6.3 ± 4.2 mL, p < 0.001). The increase in PFM volume in the MS group was significantly greater than that in other muscle parameters. No patient showed elevated prostate‐specific antigen levels (> 0.2 ng/mL), indicating no biochemical recurrence.

Conclusions

TRT was associated with reduced UI after RARP. The combination of TRT and MS may help increase PFM volume and improve urinary symptom questionnaire scores. Further accumulation of evidence is needed to clarify these synergistic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneProstatectomyUrinary IncontinenceRobotic Surgical ProceduresProstatic NeoplasmsMagnetic Field TherapyHormone Replacement TherapyHumansMaleMiddle AgedAgedQuality of LifePelvic FloorRecovery of FunctionCombined Modality TherapyHypogonadismTreatment Outcome

Stichwörter der Autor:innen

late‐onset hypogonadismmagnetic stimulationpelvic floor musclerobot‐assisted radical prostatectomytestosterone replacement therapyurinary incontinence

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Sportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Urology, Innovative Longevity, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Department of Sports Medicine and Sportology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Yoshihiro Ikehata, Takuro Kobayashi

Förderung

  • JSPS KAKENHI

Zitieren

APA

Tanaka, Y., Shimizu, F., Abudurezake, A., Diabangouaya, M., Ikehata, Y., Kobayashi, T., China, T., Tamura, Y., Ide, H., & Horie, S. (2026). Enhancing Continence Recovery After Robot‐Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation. The Prostate. https://doi.org/10.1002/pros.70205

Vancouver

Tanaka Y, Shimizu F, Abudurezake A, Diabangouaya M, Ikehata Y, Kobayashi T, et al. Enhancing Continence Recovery After Robot‐Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation. The Prostate. 2026. doi:10.1002/pros.70205

BibTeX
@article{Tanaka2026,
  author = {Tanaka, Yasunari and Shimizu, Fumitaka and Abudurezake, Abulaiti and Diabangouaya, Myriam and Ikehata, Yoshihiro and Kobayashi, Takuro and China, Toshiyuki and Tamura, Yoshifumi and Ide, Hisamitsu and Horie, Shigeo},
  title = {Enhancing Continence Recovery After Robot‐Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70205}
}
Kostenlos starten →